CORONA Remedies
CORONA · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 15, 2025

Stock Price vs Company Growth
1d
-0.0%
1w
0.4%
1m
2.2%
3m
22.7%
6m
34.9%
all
47.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,113 -0.0%
1,648
2,261
Company Overview

Sales
1,479 Cr
Growth: 12.8%
Profit after Tax
199 Cr
Growth: 7.5%
Mid Cap
12,924 Cr
P/E: 64.9x
Industry P/E: 31.7x
Fundamentals

Sales (Cr) ₹ 1,479
Growth 12.8%
EBITDA 21.4%
P/S 8.7x
Dividend 0.0%
P/E 64.9x
Book Value ₹ 132
PEG Ratio 5.1x
ROE 26.5%
P/B 16.0x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is primarily engaged in the business of manufacturing, trading and marketing of pharmaceutical products. The company also has an associate which is involved in similar line of business. Its diversified product portfolio comprises brands that cater to a range of therapeutic areas such as women’s healthcare, cardio-diabeto, pain management, urology and others/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (VMN), gastrointestinal and respiratory.